Positive spiking: a double-blind control study on its significance in behavior disorders, both diagnostically and therapeutically.
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000175:diagnosis / Q000503:physiopathology; D001538:Bender-Gestalt Test; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000175:diagnosis / Q000503:physiopathology; D004213:Dissociative Disorders / Q000175:diagnosis / Q000503:physiopathology; D004569:Electroencephalography; D005163:Factor Analysis, Statistical; D005260:Female; D006167:Guilt; D006801:Humans; D008297:Male; D008487:Medical History Taking; D009461:Neurologic Manifestations; D010555:Personality Inventory; D010672:Phenytoin / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012392:Rorschach Test; D012920:Social Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D012949:Social Work, Psychiatric; D013803:Thematic Apperception Test; D013881:Thioridazine / Q000627:therapeutic use
D010919:Placebos; D010672:Phenytoin; D013881:Thioridazine